Development of investigational radiation modifiers

J Natl Cancer Inst. 2003 May 7;95(9):646-51. doi: 10.1093/jnci/95.9.646.
No abstract available

Publication types

  • Review

MeSH terms

  • Amifostine / pharmacology
  • Animals
  • Antineoplastic Agents / pharmacology
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Critical Pathways
  • Drugs, Investigational* / pharmacology
  • Humans
  • National Institutes of Health (U.S.)
  • Neoplasms / drug therapy*
  • Neoplasms / radiotherapy*
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / radiotherapy
  • Radiation-Sensitizing Agents* / pharmacology
  • Research Design
  • United States

Substances

  • Antineoplastic Agents
  • Drugs, Investigational
  • Radiation-Sensitizing Agents
  • Amifostine